3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Squamous Cell Carcinoma of Head and Neck
2
Triple Negative Breast Neoplasms
1
Solid Tumor, Adult
1
Oligoprogressive
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Glioblastoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Interventions
Sorafenib
52
pembrolizumab
26
Nivolumab
19
Bevacizumab
19
Radiosurgery
17
Doxorubicin
12
atezolizumab
9
Erlotinib Hydrochloride
9
lenvatinib
8
tremelimumab
6
durvalumab
6
cabozantinib
6
Ramucirumab
6
Radiofrequency Ablation
6
Magnetic Resonance Spectroscopy
6
Cisplatin
6
Sunitinib
5
tislelizumab
4
regorafenib
4
Oxaliplatin
4
Leucovorin
4
Ipilimumab
4
Fluorouracil
4
Everolimus
4
Capecitabine
4
nintedanib
3
fluoromisonidazole
3
carotuximab
3
bavituximab
3
Tomography, X-Ray Computed
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Hepatocellular
×
Immune Checkpoint Inhibitors
×
Clear all
No trials found.